Zhang XG, et al. - Researchers examined the functions of CD164 in urothelial bladder carcinoma. They performed the immunohistochemistry (IHC) to assess the relationships between the expression level of CD164 and clinical-pathological features of patients, and IHC was utilized to examine the association between CD164 and CXCR4 in tumor tissues. They found a co-expression between CD164 and CXCR4 in tumor tissues. According to the findings, CD164 was correlated with poor clinical outcomes in bladder carcinoma patients.